Stay updated on PEMILA: Pelacarsen in Post-MI Patients Clinical Trial
Sign up to get notified when there's something new on the PEMILA: Pelacarsen in Post-MI Patients Clinical Trial page.

Latest updates to the PEMILA: Pelacarsen in Post-MI Patients Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedRevision: v3.3.3 has been added to the Record History, and the footer items 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' have been removed.SummaryDifference0.2%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedRevision: v3.3.2 was added to the record history, replacing v3.3.1.SummaryDifference0.1%

- Check48 days agoChange DetectedA new revision v3.3.1 is added and revision v3.2.0 is removed from the Record History.SummaryDifference0.1%

- Check55 days agoChange DetectedRemoved the lapse-in-government-funding notice from the page.SummaryDifference0.8%

- Check69 days agoChange DetectedVersion 3 (2021-12-10) updates the Recruitment Status and related fields, reflecting a change in the trial's current activity. The earlier Version 2 (2021-08-05) updated Study Status, Study Description and Outcome Measures.SummaryDifference0.1%

- Check98 days agoChange DetectedCore page content updated to include a funding-status notice and operating-status guidance, plus a version upgrade from v3.1.0 to v3.2.0.SummaryDifference13%

Stay in the know with updates to PEMILA: Pelacarsen in Post-MI Patients Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEMILA: Pelacarsen in Post-MI Patients Clinical Trial page.